C-type natriuretic peptide (CNP): The cardiovascular system and beyond

被引：2

作者：

Dickinson, Yasmin A. ^{[1
]}

Moyes, Amie J. ^{[1
]}

Hobbs, Adrian J. ^{[1
]}

机构：

[1] Queen Mary Univ London, William Harvey Res Inst, Fac Med & Dent, Barts & London, Charterhouse Sq, London EC1M 6BQ, England

来源：

PHARMACOLOGY & THERAPEUTICS | 2024年 / 262卷

基金：

英国生物技术与生命科学研究理事会;

关键词：

C -type natriuretic peptide; Natriuretic peptide receptor; Cyclic GMP; G -protein coupled receptor; Heart; Vasculature; Kidney; Metabolism; Central nervous system; RECEPTOR NPR-B; MESANGIAL CELL-PROLIFERATION; CONGESTIVE-HEART-FAILURE; FIBROBLAST-GROWTH-FACTOR; OF-FUNCTION MUTATION; GUANYLYL CYCLASE; CLEARANCE RECEPTOR; BLOOD-PRESSURE; SINOATRIAL NODE; MOUSE MODEL;

D O I：

10.1016/j.pharmthera.2024.108708

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

C-type natriuretic peptide (CNP) represents the 'local' member of the natriuretic peptide family, functioning in an autocrine or paracrine capacity to modulate a hugely diverse portfolio of physiological processes. Whilst the bestcharacterised of these regulatory roles are in the cardiovascular system, akin to its predominantly endocrine siblings atrial (ANP) and brain (BNP) natriuretic peptides, CNP governs many additional, unrelated mechanisms including bone growth, gamete maturation, auditory processing, and neuronal integrity. Furthermore, there is currently great interest in mimicking the biological activity of CNP for therapeutic gain in many of these disparate organ systems. Herein, we provide an overview of the physiology, pathophysiology and pharmacology of CNP in both cardiovascular and non-cardiovascular settings. (c) 2024 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license (http://

引用

页数：18

共 50 条

[21] Urinary C-Type Natriuretic Peptide
Zakeri, Rosita
Sangaralingham, S. Jeson
Sandberg, Sharon M.
Heublein, Denise M.
Scott, Christopher G.
Burnett, John C., Jr.
JACC-HEART FAILURE, 2013, 1 (02) : 170 - 177
[22] C-type natriuretic peptide (CNP) in endothelial cells attenuates hepatic fibrosis and inflammation in non-alcoholic steatohepatitis
Bae, Cho-Rong
Hino, Jun
Hosoda, Hiroshi
Miyazato, Mikiya
Kangawa, Kenji
LIFE SCIENCES, 2018, 209 : 349 - 356
[23] C-type natriuretic peptide: A new cardiac mediator
Del Ry, S.
PEPTIDES, 2013, 40 : 93 - 98
[24] Increased renal production of C-type natriuretic peptide (CNP) in patients with cirrhosis and functional renal failure
Gülberg, V
Moller, S
Henriksen, JH
Gerbes, AL
GUT, 2000, 47 (06) : 852 - 857
[25] Natriuretic peptide receptor 2 (NPR2) localized in bovine oocyte underlies a unique mechanism for C-type natriuretic peptide (CNP)-induced meiotic arrest
Xi, Guangyin
An, Lei
Jia, Zhenwei
Tan, Kun
Zhang, Jiaxin
Wang, Zhuqing
Zhang, Chao
Miao, Kai
Wu, Zhonghong
Tian, Jianhui
THERIOGENOLOGY, 2018, 106 : 198 - 209
[26] ROLE OF NATRIURETIC PEPTIDE CLEARANCE RECEPTOR IN IN-VIVO CONTROL OF C-TYPE NATRIURETIC PEPTIDE
BRANDT, RR
HEUBLEIN, DM
AARHUS, LL
LEWICKI, JA
BURNETT, JC
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1995, 269 (01): : H326 - H331
[27] C-type natriuretic peptide in prostate cancer
Nielsen, Soeren Junge
Iversen, Peter
Rehfeld, Jens F.
Jensen, Helle Lone
Goetze, Jens Peter
APMIS, 2009, 117 (01) : 60 - 67
[28] C-type natriuretic peptide and heart failure
Del Ry, Silvia
Passino, Claudio
Emdin, Michele
Giannessi, Daniela
PHARMACOLOGICAL RESEARCH, 2006, 54 (05) : 326 - 333
[29] C-type natriuretic peptide in childhood obesity
Cabiati, Manuela
Sgalippa, Agnese
Federico, Giovanni
Del Ry, Silvia
PEPTIDES, 2021, 145
[30] Role of C-type natriuretic peptide signalling in maintaining cartilage and bone function
Peake, N. J.
Hobbs, A. J.
Pingguan-Murphy, B.
Salter, D. M.
Berenbaum, F.
Chowdhury, T. T.
OSTEOARTHRITIS AND CARTILAGE, 2014, 22 (11) : 1800 - 1807

← 1 2 3 4 5 →